Abstract
Summary
The global Virtual Drug Discovery Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Virtual Drug Discovery Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Virtual Drug Discovery Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Virtual Drug Discovery Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Virtual Drug Discovery Service players cover Profacgen, CD ComputaBio, Creative Biolabs, BOC Sciences, Jubilant Biosys, MedChemExpress (MCE), HitGen, TargetMol Chemicals and WuXi AppTec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Virtual Drug Discovery Service Industry Forecast” looks at past sales and reviews total world Virtual Drug Discovery Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Virtual Drug Discovery Service sales for 2023 through 2029. With Virtual Drug Discovery Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virtual Drug Discovery Service industry.
This Insight Report provides a comprehensive analysis of the global Virtual Drug Discovery Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Virtual Drug Discovery Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virtual Drug Discovery Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virtual Drug Discovery Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virtual Drug Discovery Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Virtual Drug Discovery Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Others
Segmentation by application
Biotech and Pharmaceutical Companies
Academic Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
Jubilant Biosys
MedChemExpress (MCE)
HitGen
TargetMol Chemicals
WuXi AppTec
LeadBuilder - Domainex
CSNpharm
ChemNavigator
CKTTDB
Molinspiration
Molsoft
Southwest Research Institute
United States market for Virtual Drug Discovery Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Virtual Drug Discovery Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Virtual Drug Discovery Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Virtual Drug Discovery Service players cover Profacgen, CD ComputaBio, Creative Biolabs, BOC Sciences, Jubilant Biosys, MedChemExpress (MCE), HitGen, TargetMol Chemicals and WuXi AppTec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Virtual Drug Discovery Service Industry Forecast” looks at past sales and reviews total world Virtual Drug Discovery Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Virtual Drug Discovery Service sales for 2023 through 2029. With Virtual Drug Discovery Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virtual Drug Discovery Service industry.
This Insight Report provides a comprehensive analysis of the global Virtual Drug Discovery Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Virtual Drug Discovery Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virtual Drug Discovery Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virtual Drug Discovery Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virtual Drug Discovery Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Virtual Drug Discovery Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Others
Segmentation by application
Biotech and Pharmaceutical Companies
Academic Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
Jubilant Biosys
MedChemExpress (MCE)
HitGen
TargetMol Chemicals
WuXi AppTec
LeadBuilder - Domainex
CSNpharm
ChemNavigator
CKTTDB
Molinspiration
Molsoft
Southwest Research Institute
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Virtual Drug Discovery Service Market Size 2018-2029
2.1.2 Virtual Drug Discovery Service Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Virtual Drug Discovery Service Segment by Type
2.2.1 Structure-based Virtual Screening (SBVS)
2.2.2 Ligand-based Virtual Screening (LBVS)
2.2.3 Others
2.3 Virtual Drug Discovery Service Market Size by Type
2.3.1 Virtual Drug Discovery Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Virtual Drug Discovery Service Market Size Market Share by Type (2018-2023)
2.4 Virtual Drug Discovery Service Segment by Application
2.4.1 Biotech and Pharmaceutical Companies
2.4.2 Academic Institutions
2.4.3 Others
2.5 Virtual Drug Discovery Service Market Size by Application
2.5.1 Virtual Drug Discovery Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Virtual Drug Discovery Service Market Size Market Share by Application (2018-2023)
3 Virtual Drug Discovery Service Market Size by Player
3.1 Virtual Drug Discovery Service Market Size Market Share by Players
3.1.1 Global Virtual Drug Discovery Service Revenue by Players (2018-2023)
3.1.2 Global Virtual Drug Discovery Service Revenue Market Share by Players (2018-2023)
3.2 Global Virtual Drug Discovery Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Virtual Drug Discovery Service by Regions
4.1 Virtual Drug Discovery Service Market Size by Regions (2018-2023)
4.2 Americas Virtual Drug Discovery Service Market Size Growth (2018-2023)
4.3 APAC Virtual Drug Discovery Service Market Size Growth (2018-2023)
4.4 Europe Virtual Drug Discovery Service Market Size Growth (2018-2023)
4.5 Middle East & Africa Virtual Drug Discovery Service Market Size Growth (2018-2023)
5 Americas
5.1 Americas Virtual Drug Discovery Service Market Size by Country (2018-2023)
5.2 Americas Virtual Drug Discovery Service Market Size by Type (2018-2023)
5.3 Americas Virtual Drug Discovery Service Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Virtual Drug Discovery Service Market Size by Region (2018-2023)
6.2 APAC Virtual Drug Discovery Service Market Size by Type (2018-2023)
6.3 APAC Virtual Drug Discovery Service Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Virtual Drug Discovery Service by Country (2018-2023)
7.2 Europe Virtual Drug Discovery Service Market Size by Type (2018-2023)
7.3 Europe Virtual Drug Discovery Service Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Virtual Drug Discovery Service by Region (2018-2023)
8.2 Middle East & Africa Virtual Drug Discovery Service Market Size by Type (2018-2023)
8.3 Middle East & Africa Virtual Drug Discovery Service Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Virtual Drug Discovery Service Market Forecast
10.1 Global Virtual Drug Discovery Service Forecast by Regions (2024-2029)
10.1.1 Global Virtual Drug Discovery Service Forecast by Regions (2024-2029)
10.1.2 Americas Virtual Drug Discovery Service Forecast
10.1.3 APAC Virtual Drug Discovery Service Forecast
10.1.4 Europe Virtual Drug Discovery Service Forecast
10.1.5 Middle East & Africa Virtual Drug Discovery Service Forecast
10.2 Americas Virtual Drug Discovery Service Forecast by Country (2024-2029)
10.2.1 United States Virtual Drug Discovery Service Market Forecast
10.2.2 Canada Virtual Drug Discovery Service Market Forecast
10.2.3 Mexico Virtual Drug Discovery Service Market Forecast
10.2.4 Brazil Virtual Drug Discovery Service Market Forecast
10.3 APAC Virtual Drug Discovery Service Forecast by Region (2024-2029)
10.3.1 China Virtual Drug Discovery Service Market Forecast
10.3.2 Japan Virtual Drug Discovery Service Market Forecast
10.3.3 Korea Virtual Drug Discovery Service Market Forecast
10.3.4 Southeast Asia Virtual Drug Discovery Service Market Forecast
10.3.5 India Virtual Drug Discovery Service Market Forecast
10.3.6 Australia Virtual Drug Discovery Service Market Forecast
10.4 Europe Virtual Drug Discovery Service Forecast by Country (2024-2029)
10.4.1 Germany Virtual Drug Discovery Service Market Forecast
10.4.2 France Virtual Drug Discovery Service Market Forecast
10.4.3 UK Virtual Drug Discovery Service Market Forecast
10.4.4 Italy Virtual Drug Discovery Service Market Forecast
10.4.5 Russia Virtual Drug Discovery Service Market Forecast
10.5 Middle East & Africa Virtual Drug Discovery Service Forecast by Region (2024-2029)
10.5.1 Egypt Virtual Drug Discovery Service Market Forecast
10.5.2 South Africa Virtual Drug Discovery Service Market Forecast
10.5.3 Israel Virtual Drug Discovery Service Market Forecast
10.5.4 Turkey Virtual Drug Discovery Service Market Forecast
10.5.5 GCC Countries Virtual Drug Discovery Service Market Forecast
10.6 Global Virtual Drug Discovery Service Forecast by Type (2024-2029)
10.7 Global Virtual Drug Discovery Service Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Profacgen
11.1.1 Profacgen Company Information
11.1.2 Profacgen Virtual Drug Discovery Service Product Offered
11.1.3 Profacgen Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Profacgen Main Business Overview
11.1.5 Profacgen Latest Developments
11.2 CD ComputaBio
11.2.1 CD ComputaBio Company Information
11.2.2 CD ComputaBio Virtual Drug Discovery Service Product Offered
11.2.3 CD ComputaBio Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 CD ComputaBio Main Business Overview
11.2.5 CD ComputaBio Latest Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Information
11.3.2 Creative Biolabs Virtual Drug Discovery Service Product Offered
11.3.3 Creative Biolabs Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Creative Biolabs Main Business Overview
11.3.5 Creative Biolabs Latest Developments
11.4 BOC Sciences
11.4.1 BOC Sciences Company Information
11.4.2 BOC Sciences Virtual Drug Discovery Service Product Offered
11.4.3 BOC Sciences Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BOC Sciences Main Business Overview
11.4.5 BOC Sciences Latest Developments
11.5 Jubilant Biosys
11.5.1 Jubilant Biosys Company Information
11.5.2 Jubilant Biosys Virtual Drug Discovery Service Product Offered
11.5.3 Jubilant Biosys Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Jubilant Biosys Main Business Overview
11.5.5 Jubilant Biosys Latest Developments
11.6 MedChemExpress (MCE)
11.6.1 MedChemExpress (MCE) Company Information
11.6.2 MedChemExpress (MCE) Virtual Drug Discovery Service Product Offered
11.6.3 MedChemExpress (MCE) Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 MedChemExpress (MCE) Main Business Overview
11.6.5 MedChemExpress (MCE) Latest Developments
11.7 HitGen
11.7.1 HitGen Company Information
11.7.2 HitGen Virtual Drug Discovery Service Product Offered
11.7.3 HitGen Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 HitGen Main Business Overview
11.7.5 HitGen Latest Developments
11.8 TargetMol Chemicals
11.8.1 TargetMol Chemicals Company Information
11.8.2 TargetMol Chemicals Virtual Drug Discovery Service Product Offered
11.8.3 TargetMol Chemicals Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 TargetMol Chemicals Main Business Overview
11.8.5 TargetMol Chemicals Latest Developments
11.9 WuXi AppTec
11.9.1 WuXi AppTec Company Information
11.9.2 WuXi AppTec Virtual Drug Discovery Service Product Offered
11.9.3 WuXi AppTec Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 WuXi AppTec Main Business Overview
11.9.5 WuXi AppTec Latest Developments
11.10 LeadBuilder - Domainex
11.10.1 LeadBuilder - Domainex Company Information
11.10.2 LeadBuilder - Domainex Virtual Drug Discovery Service Product Offered
11.10.3 LeadBuilder - Domainex Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 LeadBuilder - Domainex Main Business Overview
11.10.5 LeadBuilder - Domainex Latest Developments
11.11 CSNpharm
11.11.1 CSNpharm Company Information
11.11.2 CSNpharm Virtual Drug Discovery Service Product Offered
11.11.3 CSNpharm Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 CSNpharm Main Business Overview
11.11.5 CSNpharm Latest Developments
11.12 ChemNavigator
11.12.1 ChemNavigator Company Information
11.12.2 ChemNavigator Virtual Drug Discovery Service Product Offered
11.12.3 ChemNavigator Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ChemNavigator Main Business Overview
11.12.5 ChemNavigator Latest Developments
11.13 CKTTDB
11.13.1 CKTTDB Company Information
11.13.2 CKTTDB Virtual Drug Discovery Service Product Offered
11.13.3 CKTTDB Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CKTTDB Main Business Overview
11.13.5 CKTTDB Latest Developments
11.14 Molinspiration
11.14.1 Molinspiration Company Information
11.14.2 Molinspiration Virtual Drug Discovery Service Product Offered
11.14.3 Molinspiration Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Molinspiration Main Business Overview
11.14.5 Molinspiration Latest Developments
11.15 Molsoft
11.15.1 Molsoft Company Information
11.15.2 Molsoft Virtual Drug Discovery Service Product Offered
11.15.3 Molsoft Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Molsoft Main Business Overview
11.15.5 Molsoft Latest Developments
11.16 Southwest Research Institute
11.16.1 Southwest Research Institute Company Information
11.16.2 Southwest Research Institute Virtual Drug Discovery Service Product Offered
11.16.3 Southwest Research Institute Virtual Drug Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Southwest Research Institute Main Business Overview
11.16.5 Southwest Research Institute Latest Developments
12 Research Findings and Conclusion